BioSpace News Archive

OnPoint Surgical, Inc., a privately held medical technology company pioneering Augmented Reality (AR) guidance for multiple spine, neurosurgical, and robotic procedures, today announced that it will participate in the 39th Annual J.P. Morgan Healthcare Conference

NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced the pricing of an underwritten public offering of 4,629,630 shares of its common stock at a price to the public of $27.00 per share.

The latest business intelligence report on ‘global immunoprotein diagnostic testing market’ uncovers the ins and outs of this business sphere with respect to the current and past business landscape.

With the ubiquity of mobile phones influencing almost every aspect of human life, mHealth has emerged as a popular new tool for ensuring physical and emotional wellbeing of individuals across the globe.

Also known as genome editing, gene editing refers to a method used by scientists to make alterations in the DNA of living organisms including animals, plants, and bacteria.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the ICR Conference 2021,